Gene · 338399
Papers2,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,833
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Mitochondrial Dysfunction in Alzheimer's: Molecular Defects and Mitophagy-Enhancing Approaches. | Life (Basel) | 2023 | 37109499 | PubTator, text mining | PubMed |
| FTY720-P, a Biased S1PR Ligand, Increases Mitochondrial Function through STAT3 Activation in Cardiac Cells. | Int J Mol Sci | 2023 | 37108539 | PubTator, text mining | PubMed |
| Circulating CD137+ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients. | Int J Mol Sci | 2023 | 37108276 | PubTator, text mining | PubMed |
| Humanin and Its Pathophysiological Roles in Aging: A Systematic Review. | Biology (Basel) | 2023 | 37106758 | PubTator, text mining | PubMed |
| Spinocerebellar ataxia type 14 (SCA14) in an Argentinian family: a case report. | J Med Case Rep | 2023 | 37101238 | PubTator, text mining | PubMed |
| Identification of oxidative stress-related genes differentially expressed in Alzheimer's disease and construction of a hub gene-based diagnostic model. | Sci Rep | 2023 | 37100862 | PubTator, text mining | PubMed |
| Ataxic speech disorders and Parkinson's disease diagnostics via stochastic embedding of empirical mode decomposition. | PLoS One | 2023 | 37099544 | PubTator, text mining | PubMed |
| Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial. | Nat Med | 2023 | 37095250 | PubTator, text mining | PubMed |
| Neuroprotective effects of resistance physical exercise on the APP/PS1 mouse model of Alzheimer's disease. | Front Neurosci | 2023 | 37090809 | PubTator, text mining | PubMed |
| Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer's disease. | Mol Neurodegener | 2023 | 37085942 | PubTator, text mining | PubMed |
| T cell aging and Alzheimer's disease. | Front Immunol | 2023 | 37081887 | PubTator, text mining | PubMed |
| A somato-cognitive action network alternates with effector regions in motor cortex. | Nature | 2023 | 37076628 | PubTator, text mining | PubMed |
| Gut Microbiota and its Metabolites: Bridge of Dietary Nutrients and Alzheimer's Disease. | Adv Nutr | 2023 | 37075947 | PubTator, text mining | PubMed |
| β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog training. | J Virol Methods | 2023 | 37068591 | PubTator, text mining | PubMed |
| WFS1 autosomal dominant variants linked with hearing loss: update on structural analysis and cochlear implant outcome. | BMC Med Genomics | 2023 | 37041640 | PubTator, text mining | PubMed |
| Prognostic effect of cachexia in patients with non-small cell lung cancer receiving immune checkpoint inhibitors. | Thorac Cancer | 2023 | 37037511 | PubTator, text mining | PubMed |
| Alterations in theta-gamma coupling and sharp wave-ripple, signs of prodromal hippocampal network impairment in the TgF344-AD rat model. | Front Aging Neurosci | 2023 | 37032829 | PubTator, text mining | PubMed |
| Activation of ventral tegmental area vesicular GABA transporter (Vgat) neurons alleviates social defeat stress-induced anxiety in APP/PS1 mice. | Front Aging Neurosci | 2023 | 37032820 | PubTator, text mining | PubMed |
| N'-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile. | J Med Chem | 2023 | 37021830 | PubTator, text mining | PubMed |
| Non-collinear magnetism in the post-perovskite thiocyanate frameworks CsM(NCS)3. | Chem Sci | 2023 | 37006672 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338399/papers?page=20